Page 51 - Read Online

Hervas et al. J Transl Genet Genom 2021;5:278-87 https://dx.doi.org/10.20517/jtgg.2021.25 Page 286

gene variants in children with autism spectrum disorders. Pharmacogenomics J 2014;14:295-302. DOI PubMed PMC
15. Correia CT, Almeida JP, Santos PE, et al. Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate
genes with drug efficacy and adverse drug reactions. Pharmacogenomics J 2010;10:418-30. DOI PubMed
16. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am
J Hum Genet 2007;81:559-75. DOI PubMed PMC
17. Gadow KD, Pinsonneault JK, Perlman G, Sadee W. Association of dopamine gene variants, emotion dysregulation and ADHD in
autism spectrum disorder. Res Dev Disabil 2014;35:1658-65. DOI PubMed PMC
18. Froehlich TE, Epstein JN, Nick TG, et al. Pharmacogenetic predictors of methylphenidate dose-response in attention-
deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2011;50:1129-1139.e2. DOI PubMed PMC
19. Akay AP, Resmi H, Güney SA, et al. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-
deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study. Eur Child Adolesc
Psychiatry 2018;27:127-35. DOI PubMed
20. Winsberg BG, Comings DE. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J Am Acad
Child Adolesc Psychiatry 1999;38:1474-7. DOI PubMed
21. Nuntamool N, Ngamsamut N, Vanwong N, et al. Pharmacogenomics and efficacy of risperidone long-term treatment in Thai autistic
children and adolescents. Basic Clin Pharmacol Toxicol 2017;121:316-24. DOI PubMed
22. Tharoor H, Lobos EA, Todd RD, Reiersen AM. Association of dopamine, serotonin, and nicotinic gene polymorphisms with
methylphenidate response in ADHD. Am J Med Genet B Neuropsychiatr Genet 2008;147B:527-30. DOI PubMed
23. Ji HS, Paik KC, Park WS, Lim MH. No association between the response to methylphenidate and DRD4 gene polymorphism in korean
attention deficit hyperactivity disorder: a case control study. Clin Psychopharmacol Neurosci 2013;11:13-7. DOI PubMed PMC
24. Zeni CP, Guimarães AP, Polanczyk GV, et al. No significant association between response to methylphenidate and genes of the
dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder. Am J Med Genet
B Neuropsychiatr Genet 2007;144B:391-4. DOI PubMed
25. Sukasem C, Vanwong N, Srisawasdi P, et al. Pharmacogenetics of risperidone-induced insulin resistance in children and adolescents
with autism spectrum disorder. Basic Clin Pharmacol Toxicol 2018;123:42-50. DOI PubMed
26. Oblak A, Gibbs TT, Blatt GJ. Reduced serotonin receptor subtypes in a limbic and a neocortical region in autism. Autism Res
2013;6:571-83. DOI PubMed PMC
27. Park YH, Lee KK, Kwon HJ, et al. Association between HTR1A gene polymorphisms and attention deficit hyperactivity disorder in
Korean children. Genet Test Mol Biomarkers 2013;17:178-82. DOI PubMed
28. Abdelrahman HM, Sherief LM, Alghobashy AA, et al. Association of 5-HT2A receptor gene polymorphisms with gastrointestinal
disorders in Egyptian children with autistic disorder. Res Dev Disabil 2015;36C:485-90. DOI PubMed
29. Smith RM, Banks W, Hansen E, Sadee W, Herman GE. Family-based clinical associations and functional characterization of the
serotonin 2A receptor gene (HTR2A) in autism spectrum disorder. Autism Res 2014;7:459-67. DOI PubMed PMC
30. Hervás A, Toma C, Romarís P, et al. The involvement of serotonin polymorphisms in autistic spectrum symptomatology. Psychiatr
Genet 2014;24:158-63. DOI PubMed
31. Gadow KD, Smith RM, Pinsonneault JK. Serotonin 2A receptor gene (HTR2A) regulatory variants: possible association with severity
of depression symptoms in children with autism spectrum disorder. Cogn Behav Neurol 2014;27:107-16. DOI PubMed
32. Valencia AV, Páez AL, Sampedro ME, et al. [Evidence for association and epistasis between the genetic markers SLC6A4 and
HTR2A in autism etiology]. Biomedica 2012;32:585-601. DOI PubMed
33. Al-Janabi I, Arranz MJ, Blakemore AI, et al. Association study of serotonergic gene variants with antipsychotic-induced adverse
reactions. Psychiatr Genet 2009;19:305-11. DOI PubMed
34. Arranz MJ, Salazar J, Hernández MH. Pharmacogenetics of antipsychotics: clinical utility and implementation. Behav Brain Res
2021;401:113058. DOI PubMed
35. Takekita Y, Fabbri C, Kato M, et al. HTR1A polymorphisms and clinical efficacy of antipsychotic drug treatment in schizophrenia: a
meta-analysis. Int J Neuropsychopharmacol 2016;19:pyv125. DOI PubMed PMC
36. Zhao X, Huang Y, Li J, et al. Association between the 5-HT1A receptor gene polymorphism (rs6295) and antidepressants: a meta-
analysis. Int Clin Psychopharmacol 2012;27:314-20. DOI PubMed
37. Hazelwood LA, Sanders-Bush E. His452Tyr polymorphism in the human 5-HT2A receptor destabilizes the signaling conformation.
Mol Pharmacol. 2004;66:1293-300. PubMed
38. Li P, Tiwari HK, Lin WY, et al. Genetic association analysis of 30 genes related to obesity in a European American population. Int J
Obes (Lond) 2014;38:724-9. DOI PubMed PMC
39. Zhao X, Sun L, Sun YH, et al. Association of HTR2A T102C and A-1438G polymorphisms with susceptibility to major depressive
disorder: a meta-analysis. Neurol Sci 2014;35:1857-66. DOI PubMed
40. Reynolds GP, Hill MJ, Kirk SL. The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics. J
Psychopharmacol 2006;20:15-8. DOI PubMed
41. Saghazadeh A, Rezaei N. Brain-derived neurotrophic factor levels in autism: a systematic review and meta-analysis. J Autism Dev
Disord 2017;47:1018-29. DOI PubMed
42. Amiri A, Torabi Parizi G, Kousha M, et al. Changes in plasma brain-derived neurotrophic factor (BDNF) levels induced by
methylphenidate in children with Attention deficit-hyperactivity disorder (ADHD). Prog Neuropsychopharmacol Biol Psychiatry
2013;47:20-4. DOI PubMed
43. Yoo HJ, Yang SY, Cho IH, Park M, Kim SA. Polymorphisms of BDNF gene and autism spectrum disorders: family based association